DMII logo

DRUGS MADE IN AMERICA ACQUIS

DMIINASDAQ
πŸ† #2703 by market capUS Equity
$10.20β–² $0.00 (+0.00%)
Latest quote
πŸ””
Track DMII
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.0%
7dβ–² 0.1%
14dβ–² 0.1%
30dβ–² 0.3%
ytdβ–² 3.3%
1yβ€”
🏦Market Cap
$650M
Small Cap
πŸ“ˆRevenue Growth (YoY)
β€”
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
β€”
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$10.20 – $10.21
52-Week Range
$9.86 – $10.33
Volume (shares)
607
Avg Volume (shares)
β€”
Shares Outstanding
63.7M
Next Earnings
β€”

Fundamentals Snapshot

Annual Revenue
β€”
Last Q Revenue
β€”
P/E Ratio
49.9
P/S Ratio
β€”
EPS (TTM)
$0.81
Dividend Yield
β€”
Dilution (1yr)
+1.1%
DMII logo

DRUGS MADE IN AMERICA ACQUIS

DMII
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$1Mβ–² +757.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$1Mβ–² +424.1% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
64.4Mβ–² +1.1% YoY
StockOtter Β· stockotter.space

About DRUGS MADE IN AMERICA ACQUIS

Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.